Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adam Dicker

Radiation Oncology Philadelphia, PA Medical Doctor

NPI 1558383984 CMS profile 1090622

111 S 11Th St, Bodine Center, Philadelphia, PA 19107

Open in the dashboard

General payments

$46,183

63 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$39,562 paid to institutions, not to them · program years 2019–2020

Through program year 2025, Adam Dicker of Philadelphia, PA is reported in the CMS Open Payments database as having received $46,183 across 63 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $39,562 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Radiation Oncology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,692 12
2024 General $3,478 2
2023 General $3,381 17
2022 General $6,547 3
2021 General $5,207 5
2020 General $16,643 7
2019 General $9,234 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adam Dicker
  • Radiation Oncology median
  • Middle half of Radiation Oncology
  • National median

In program year 2025, general payments to Adam Dicker were reported at $1,692. Among 3,409 Radiation Oncology profiles paid that year, the median was $172 and the middle half received between $61 and $514.

Show as a table
Year Adam Dicker Radiation Oncology median Middle half National median
2019 $9,234 $138 $48–$462 $163
2020 $16,643 $79 $26–$262 $114
2021 $5,207 $119 $37–$358 $132
2022 $6,547 $139 $43–$424 $149
2023 $3,381 $167 $57–$473 $160
2024 $3,478 $168 $56–$541 $164
2025 $1,692 $172 $61–$514 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Janssen Research & Development, LLC $11,425 6 payments
  2. EMD Serono, Inc. $10,703 10 payments
  3. Roche Diagnostics Corporation $8,143 4 payments
  4. Genentech, Inc. $5,879 2 payments
  5. Varian Medical Systems, Inc. $2,600 3 payments
  6. Siemens Medical Solutions USA, Inc. $1,942 15 payments
  7. RefleXion Medical, Inc. $1,702 6 payments
  8. Ion Beam Applications S.A. $1,500 1 payment
  9. Merck Sharp & Dohme Corporation $1,000 1 payment
  10. Genzyme Corporation $577 4 payments
  11. Other $710 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $29,574 12 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,000 2 payments
  3. Travel and Lodging $4,362 14 payments
  4. Honoraria $3,500 2 payments
  5. Food and Beverage $2,747 33 payments
Products named General payments · program years 2019–2025
  1. DIS Navify Software $8,143 4 payments
  2. REFLEXION MEDICAL RADIOTHERAPY SYSTEM $1,702 6 payments
  3. Varian Treatment $1,514 11 payments
  4. OTHER $582 1 payment
  5. NO PRODUCT DISCUSSED $577 4 payments
  6. PTS250 $530 8 payments
  7. ERLEADA $253 2 payments
  8. SOMATOM go.Top $51 1 payment
  9. MAGNETOM Aera $51 1 payment
  10. Axumin $49 1 payment
  11. Other $29 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

63 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Radiation Oncology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record